Abstract
Diabetic neuropathy (DN) is characterized as Hyperglycemia activates thdisturbed nerve conduction and progressive chronic pain. Inflammatory mediators, particularly cytokines, have a determinant role in the pathogenesis of neuropathic pain. The activity of adenosine monophosphate protein kinase (AMPK), an energy charge sensor with neuroprotective properties, is decreased in diabetes. It has been reported that activation of AMPK reduces the systemic inflammation through inhibition of cytokines. In this study, we aimed to investigate the probable protective effects of AMPK on DN in a rat of diabetes. DN was induced by injection of streptozotocin (65 mg/kg, i.p.). Motor nerve conduction velocities (MNCV) of the sciatic nerve, as an electrophysiological marker for peripheral nerve damage, were measured. Plasma levels of IL-6, TNF-α, CRP were assessed as relevant markers for inflammatory response. Also, the expression of phosphorylated AMPK (p-AMPK) and non-phosphorylated (non-p-AMPK) was evaluated by western blotting in the dorsal root ganglia. Histopathological assessment was performed to determine the extent of nerve damage in sciatic nerve. Our findings showed that activation of AMPK by metformin (300 mg/kg) significantly increased the MNCV and reduced the levels of inflammatory cytokines. In addition, we showed that administration of metformin increased the expression of p-AMPK as well as decline in the level of non p-AMPK. Our results demonstrated that co-administration of dorsomorphin with metformin reversed the beneficial effects of metformin. In conclusion, the results of this study demonstrated that the activation of AMPK signaling pathway in diabetic neuropathy might be associated with the anti-inflammatory response.
Graphical abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akbar DH (2003) Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome. Endocrine 20:215–218. doi:10.1385/endo:20:3:215
Bordet T et al (2008) Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. J Pharmacol Exp Ther 326:623–632. doi:10.1124/jpet.108.139410
Boyer JS, Morgan MM, Craft RM (1998) Microinjection of morphine into the rostral ventromedial medulla produces greater antinociception in male compared to female rats. Brain Res 796:315–318. doi:10.1016/S0006-8993(98)00353-9
Brummett CM, Padda AK, Amodeo FS, Welch KB, Lydic R (2009) Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat. Anesthesiology 111:1111–1119. doi:10.1097/ALN.0b013e3181bbcc26
Cheng JT, Huang CC, Liu IM, Tzeng TF, Chang CJ (2006) Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats. Diabetes 55:819–825. doi:10.2337/diabetes.55.03.06.db05-0934
Cho K et al (2015) Antihyperglycemic mechanism of metformin occurs via the AMPK/LXR [agr]/POMC pathway. Sci Rep 5:8145. doi:10.1038/srep08145
Correia S et al (2008) Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes. Med Chem [Shariqah (United Arab Emirates)] 4:358–364. doi:10.2174/157340608784872299
Coste T, Gerbi A, Vague P, Maixent J, Pieroni G, Raccah D (2004) Peripheral diabetic neuropathy and polyunsaturated fatty acid supplementations: natural sources or biotechnological needs? Cell Mol Biol (Noisy-le-Grand, France) 50:845–853. doi:10.1070/T578
Eslami A, Lujan J (2010) Western blotting: sample preparation to detection. J Vis Exp JoVE. doi:10.3791/2359
Fillingim RB, Maixner W (1995) Gender differences in the responses to noxious stimuli. Pain Forum 4:209–221. doi:10.1016/S1082-3174(11)80022-X
Foretz M et al (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Investig 120:2355–2369. doi:10.1172/jci40671
Gaskin FS, Kamada K, Yusof M, Korthuis RJ (2007) 5′-AMP-activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 292:H326–H332. doi:10.1152/ajpheart.00744.2006
Gerich J, Raskin P, Jean-Louis L, Purkayastha D, Baron MA (2005) PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin. Diabetes Care 28:2093–2099. doi:10.2337/diacare.28.9.2093
Gonzalez-Clemente JM et al (2005) Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus. Clin Endocrinol 63:525–529. doi:10.1111/j.1365-2265.2005.02376.x
Hasegawa T et al (2006) Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats. Exp Neurol 199:274–280. doi:10.1016/j.expneurol.2005.11.001
Hills CE, Brunskill NJ (2009) Cellular and physiological effects of C-peptide. Clin Sci (London, England: 1979) 116:565–574. doi:10.1042/cs20080441
Ido Y, Carling D, Ruderman N (2002) Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 51:159–167. doi:10.2337/diabetes.51.1.159
Jin HY, Liu WJ, Park JH, Baek HS, Park TS (2009) Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats. Arch Med Res 40:536–544. doi:10.1016/j.arcmed.2009.09.005
Kimura T, Kato E, Machikawa T, Kimura S, Katayama S, Kawabata J (2014) Hydroxylamine enhances glucose uptake in C2C12 skeletal muscle cells through the activation of insulin receptor substrate 1. Biochem Biophys Res Commun 445:6–9. doi:10.1016/j.bbrc.2014.01.039
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403. doi:10.1056/NEJMoa012512
Lee MJ et al (2007) A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Ren Physiol 292:F617–F627. doi:10.1152/ajprenal.00278.2006
Leinninger GM, Edwards JL, Lipshaw MJ, Feldman EL (2006) Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol 2:620–628. doi:10.1038/ncpneuro0320
Liu X, Chhipa RR, Nakano I, Dasgupta B (2014) The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent. Mol Cancer Ther 13:596–605. doi:10.1158/1535-7163.mct-13-0579
Ma J, Liu J, Yu H, Chen Y, Wang Q, Xiang L (2015) Beneficial effect of metformin on nerve regeneration and functional recovery after sciatic nerve crush injury in diabetic rats. Neurochem Res 1–8. doi:10.1007/s11064-015-1803-y
McGee SL, van Denderen BJ, Howlett KF, Mollica J, Schertzer JD, Kemp BE, Hargreaves M (2008) AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57:860–867. doi:10.2337/db07-0843
Novikova DS, Garabadzhiu AV, Melino G, Barlev NA, Tribulovich VG (2015) AMP-activated protein kinase: structure, function, and role in pathological processes. Biochem Biokhimiia 80:127–144. doi:10.1134/s0006297915020017
Roy Chowdhury SK et al (2012) Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes. Brain J Neurol 135:1751–1766. doi:10.1093/brain/aws097
Saeedi Saravi SS, Hasanvand A, Shahkarami K, Dehpour AR (2016) The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB/C mice. Pharm Biol 1–8. doi:10.1080/13880209.2016.1185633
Steinberg GR et al (2006) Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab 4:465–474. doi:10.1016/j.cmet.2006.11.005
Takeuchi M, Takino J, Yamagishi S (2010) Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy. Curr Drug Targets 11:1468–1482. doi:10.2174/1389450111009011468
Tracy JA, Dyck PJB (2008) The spectrum of diabetic neuropathies physical medicine and rehabilitation clinics of North America 19:1–26. doi:10.1016/j.pmr.2007.10.010
Uceyler N, Rogausch JP, Toyka KV, Sommer C (2007) Differential expression of cytokines in painful and painless neuropathies. Neurology 69:42–49. doi:10.1212/01.wnl.0000265062.92340.a5
Ullah I, Ullah N, Naseer MI, Lee HY, Kim MO (2012) Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons. BMC Neurosci 13:11. doi:10.1186/1471-2202-13-11
Valk GD, Kriegsman DM, Assendelft WJ (2002) Patient education for preventing diabetic foot ulceration a systematic review. Endocrinol Metab Clin N Am 31:633–658. doi:10.1016/S0889-8529(02)00021-X
Vinik AI, Kong X, Megerian JT, Gozani SN (2006) Diabetic nerve conduction abnormalities in the primary care setting. Diabetes Technol Ther 8:654–662. doi:10.1089/dia.2006.8.654
Wada R, Yagihashi S (2005) Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann N Y Acad Sci 1043:598–604. doi:10.1196/annals.1338.067
Wang MY, Unger RH (2005) Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone. Am J Physiol Endocrinol Metab 288:E216–E221. doi:10.1152/ajpendo.00004.2004
Wang S, Xu J, Song P, Viollet B, Zou MH (2009) In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I. Diabetes 58:1893–1901. doi:10.2337/db09-0267
Wiesenfeld-Hallin Z (2005) Sex differences in pain perception. Gend Med 2:137–145. doi:10.1016/S1550-8579(05)80042-7
Wu Y, Song P, Xu J, Zhang M, Zou M-H (2007) Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J Biol Chem 282:9777–9788. doi:10.1074/jbc.M608310200
Yorek MA et al (1993) Reduced motor nerve conduction velocity and Na (+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation. Diabetes 42:1401–1406. doi:10.2337/diab.42.10.1401
Zakikhani M, Dowling RJ, Sonenberg N, Pollak MN (2008) The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. Cancer Prev Res (Philadelphia, Pa) 1:369–375. doi:10.1158/1940-6207.capr-08-0081
Zangiabadi N, Ahrari MN, Nakhaee N (2007) The effect of omega-3 fatty acids on nerve conduction velocity (NCV) and F-wave latency in patients with diabetic polyneuropathy. Am J Pharmacol Toxicol 2:1–3. doi:10.3844/ajptsp.2007.1.3
Zhang H, Zhang H, Dougherty PM (2013) Dynamic effects of TNF-alpha on synaptic transmission in mice over time following sciatic nerve chronic constriction injury. J Neurophysiol 110:1663–1671. doi:10.1152/jn.01088.2012
Zhou G et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Investig 108:1167–1174. doi:10.1172/jci13505
Zhuo XZ et al (2013) Isoproterenol instigates cardiomyocyte apoptosis and heart failure via AMPK inactivation-mediated endoplasmic reticulum stress. Apoptosis Int J Program Cell Death 18:800–810. doi:10.1007/s10495-013-0843-5
Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109–110. doi:10.1016/0304-3959(83)90201-4
Acknowledgments
This study was conducted with the support of Tehran University of Medical Sciences with Grant Number of 93-02-103-25681.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest in the matter related to this article.
Rights and permissions
About this article
Cite this article
Hasanvand, A., Amini-khoei, H., Hadian, MR. et al. Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy. Inflammopharmacol 24, 207–219 (2016). https://doi.org/10.1007/s10787-016-0275-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-016-0275-2